SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
Disc Medicine Inc
Common Stock, par value $0.0001 per share · CUSIP: 254604101
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 1,026,489.00 · Class: 3.0%
- FHMLSP, L.P.
Shares: 1,026,489.00 · Class: 3.0%
- FHMLSP, L.L.C.
Shares: 1,026,489.00 · Class: 3.0%
- Frazier Life Sciences Public Overage Fund, L.P.
Shares: 300,643.00 · Class: 0.9%
- FHMLSP Overage, L.P.
Shares: 300,643.00 · Class: 0.9%
- FHMLSP Overage, L.L.C.
Shares: 300,643.00 · Class: 0.9%
- Frazier Life Sciences X, L.P.
Shares: 63,218.00 · Class: 0.2%
- FHMLS X, L.P.
Shares: 63,218.00 · Class: 0.2%
- FHMLS X, L.L.C.
Shares: 63,218.00 · Class: 0.2%
- Frazier Life Sciences XI, L.P.
Shares: 264,484.00 · Class: 0.8%
- FHMLS XI, L.P.
Shares: 264,484.00 · Class: 0.8%
- FHMLS XI, L.L.C.
Shares: 264,484.00 · Class: 0.8%
- James N. Topper
Shares: 63,218.00 · Class: 0.2%
- Patrick J. Heron
Shares: 63,218.00 · Class: 0.2%
- Albert Cha
Shares: 0.00 · Class: 0.0%
- James Brush
Shares: 0.00 · Class: 0.0%
- Daniel Estes
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021785
- Form type
- SCHEDULE 13G/A
- Filer
- Disc Medicine, Inc.
- CIK
- CIK 1816736
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership